Previous work by us and others indicates that BRG1 is overexpressed in most breast tumors regardless of classification and that BRG1 knockdown in triple negative breast cancer cells caused a slow proliferation phenotype [27, 33]. Here, SMARCA4 is linked to breast neoplasm.